A.A. BAYAZITOVA^1,2, N.I. GLUSHKO¹, S.A. LISOVSKAYA¹, E.V. KHALDEEVA¹, V.R. PARSHAKOV¹, O.N. ILYINSKAYA²

¹Kazan Research Institute of Epidemiology and Microbiology of the Russian Agency for Consumer Supervision, 67 Bolshaya Krasnaya Str., Kazan, Russian Federation, 420015

²Kazan Federal University, 18 Kremlevskaya Str., Kazan, Russian Federation, 420008

Bayazitova A.A. ― Senior laboratory assistant of Mycology Laboratory, postgraduate student of Microbiology Department, tel. (843) 236-56-59, e-mail: alien2110@gmail.com

Glushko N.I. ― Senior Researcher of Mycology Laboratory, tel. (843) 236-56-59, e-mail: Glushko_NI@mail.ru

Lisovskaya S.A. ― Cand. Biol. Sc., Leading Researcher of Mycology Laboratory, tel. (843) 236-56-59, e-mail: S_Lisovskaya@mail.ru

Khaldeeva E.V. ― Cand. Chem. Sc., Head of Mycology Laboratory, tel. (843) 236-56-59, e-mail: mycology-kazan@yandex.ru

Parshakov V.R. ― Junior Researcher of Mycology Laboratory, tel. (843) 236-56-59, e-mail: mycology-kazan@yandex.ru

Ilyinskaya O.N. ― D. Biol. Sc., Professor, Head of Microbiology Department, tel. (843) 233-78-55, e-mail: Olga.Ilinskaya@kpfu.ru

The risk of fungal allergy, along with the ability to cause mycosis and to have toxic effects, is one of the important medical properties of fungi. This review covers the fungi of the genus Aspergillus, in particular Aspergillus niger and Aspergillus fumigatus, as one of the most important sources of inhalant allergens. The assessment of the allergenicity of Aspergillus niger and Aspergillus fumigatus, and detailed description of the most significant allergens are provided.

Key words: Aspergillus niger, Aspergillus fumigatus, allergy, allergens, fungi.

REFERENCES

1. http://fightthecauseofallergy.org (accessed: 13.04.2016)
2. https://www.niaid.nih.gov/Pages/default.aspx (accessed: 13.04.2016)
3. Patterson R., Gremmer L.K., Grinberger P.A. Allergicheskie bolezni: diagnostika i lechenie [Allergic diseases: diagnosis and treatment]. GEOTAR MEDITsINA, 2000. 768 p.
4. Licorish K. et al. Role of Altemaria and Penicillium spores in the pathogenesis of asthma I I. J. Allergy Clin. Immunol., 1985, vol. 76, p. 819.
5. Pepys J. et al. Hypersensitivity diseases of the lungs due to fungi and organic dusts. Monographs in Allergy, 1969, vol. 4.
6. Vermani M., Vijayan V.K., Agarwal M.K. Identification of Aspergillus (A flavus and A niger) Allergens and Heterogeneity of Allergic Patients’ IgE Response. Iranian Journal of Allergy, Asthma and Immunology, 2015, vol. 14, no. 4, p. 361.
7. Pasternaya N.N., Brysin V.G. Allergennost’ plesnevykh gribov [Allergenic molds]. Tashkent: Meditsina, 1975. 75 p.
8. Topping M.D. et al. Clinical and immunological reactions to Aspergillus niger among workers at a biotechnology plant. British Journal of Industrial Medicine, 1985, vol. 42, no. 5, pp. 312-318.
9. Nigam S., Ghosh P.C., Sarma P.U. A new glycoprotein allergen/antigen with the protease activity from Aspergillus fumigatus. International archives of allergy and immunology, 2003, vol. 132, no. 2, pp. 124-131.
10. Bush R.K., Yunginger J.W. Standardization of fungal allergens. Clin. Rev. Allergy, 1987, vol. 5, p. 3.
11. http://allergen.org (accessed: 13.04.2016)
12. Sander I. et al. Allergy to Aspergillus-derived enzymes in the baking industry: identification of β-xylosidase from Aspergillus niger as a new allergen (Asp n 14). Journal of allergy and clinical immunology, 1998, vol. 102, no. 2, pp. 256-264.
13. Lockey R.F. Allergens and allergen immunotherapy, CRC Press, 2004. 750 p.
14. http://www.fao.org/fileadmin/user_upload/agns/pdf/CTA_Phytase_from_Aspergillus_Niger_Final.pdf (accessed: 13.04.2016)
15. Banerjee B., Greenberger P.A., Fink J.N., Kurup V.P. Molecular characterization of Aspergillus fumigatus allergens. Indian Journal Of Chest Diseases And Allied Sciences, 2000, vol. 42, no. 4, pp. 239-248.
16. Sporik R.B., Arruda L.K., Woodfolk J. et al. Environmental exposure to Aspergillus fumigatus allergen (Asp f I). Clinical & Experimental Allergy, 1993, vol. 23, no. 4, pp. 326-331.
17. Moser M., Crameri R., Menz G. et al. Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity. The Journal of Immunology, 1992, vol. 149, no. 2, pp. 454-460.
18. Disch R., Menz G., Blaser K., Crameri R. Different reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with atopic dermatitis or allergic asthma sensitised to Aspergillus fumigatus. International archives of allergy and immunology, 1995, vol. 108, no. 1, pp. 89-94.
19. Nikolaizik W.H., Moser M., Crameri R. et al. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. American journal of respiratory and critical care medicine, 1995, vol. 152, no. 2, pp. 634-639.
20. El-Dahr J.M., Fink R., Selden R. et al. Development of immune responses to Aspergillus at an early age in children with cystic fibrosis. American journal of respiratory and critical care medicine, 1994, vol. 150, no. 6, pp. 1513-1518.
21. Crameri R., Lidholm J., Gronlund H. et al. Automated specific IgE assay with recombinant allergens: evaluation of the recombinant Aspergillus fumigatus allergen I in the Pharmacia Cap System. Clinical & Experimental Allergy, 1996, vol. 26, no. 12, pp. 1411-1419.
22. http://www.phadia.com/ (accessed: 13.04.2016)
23. Banerjee B., Kurup V.P., Greenberger P.A. et al. Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell‐mediated immunity in allergic bronchopulmonary aspergillosis (ABPA). Clinical & Experimental Allergy, 2001, vol. 31, no. 5, pp. 761-770.